Clinical Trial Update: Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Belumosudil to address interstitial fibrosis and tubular atrophy following kidney transplantation, in the context of rejection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Fibrosis and Tubular Atrophy After Kidney Transplantation
• Kidney Transplant Rejection
• Kidney Transplantation

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Rejection Chronic Renal | Phase 2 | Status: ENROLLING_BY_INVITATION